Clinical Trial Update: Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating intrapleural instillation of nivolumab in cancer patients with pleural effusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer Metastatic
• Pleural Effusion Malignant
• Renal Cell Cancer Metastatic

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Kidney Cancer Research Bureau | Conditions: Renal Cell Cancer Metastatic, Non-small Cell Lung Cancer Metastatic | Phase 2 | Status: COMPLETED